Advertisement

Journal of Autism and Developmental Disorders

, Volume 38, Issue 6, pp 1066–1071 | Cite as

Intestinal Permeability and Glucagon-like peptide-2 in Children with Autism: A Controlled Pilot Study

  • Marli A. Robertson
  • David L. Sigalet
  • Jens J.  Holst
  • Jon B. Meddings
  • Julie Wood
  • Keith A. Sharkey
Original Paper

Abstract

We measured small intestinal permeability using a lactulose:mannitol sugar permeability test in a group of children with autism, with current or previous gastrointestinal complaints. Secondly, we examined whether children with autism had an abnormal glucagon-like peptide-2 (GLP-2) response to feeding. Results were compared with sibling controls and children without developmental disabilities. We enrolled 14 children with autism, 7 developmentally normal siblings of these children and 8 healthy, developmentally normal, unrelated children. Our study did not detect differences in these measures of gastrointestinal function in a group of children with autism.

Keywords

Autism Nutrition Intestinal permeability Glucagon-like peptide 2 

Notes

Acknowledgements

We extend thanks to Laurie Wallace, Cathy Osadetz, Sue Smylie for research assistance, David Johnson MD for statistical analysis, as well as all the families who volunteered to participate in this study. This project was funded by the Jonty Foundation, Minnesota, USA.

References

  1. Ahearn, W. H., Castine, T., Nault, K., & Green, G. (2001). An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. Journal of Autism and Developmental Disorders, 31(5), 505–511.PubMedCrossRefGoogle Scholar
  2. Blaxill, M. F. (2004). What’s going on? The question of time trends in autism. Public Health Reports, 119(6), 536–551.PubMedCrossRefGoogle Scholar
  3. Breslin, N. P., Nash, C., Hilsden, R. J., Hershfield, N. B., Price, L. M., Meddings, J. B., & Sutherland, L. R. (2001). Intestinal permeability is increased in a proportion of spouses of patients with Crohn’s disease. The American Journal of Gastroenterology, 96(10), 2934–2938.PubMedCrossRefGoogle Scholar
  4. Chakrabarti, S., & Fombonne, E. (2005). Pervasive developmental disorders in preschool children: confirmation of high prevalence. The American Journal of Psychiatry, 162(6), 1133–1141.PubMedCrossRefGoogle Scholar
  5. Charman, T. (2002). The prevalence of autism spectrum disorders. Recent evidence and future challenges. European Child & Adolescent Psychiatry, 11(6), 249–256.CrossRefGoogle Scholar
  6. D’Eufemia, P., Celli, M., Finocchiaro, R., Pacifico, L., Viozzi, L., Zaccagnini, M., Cardi, E., & Giardini, O. (1996). Abnormal intestinal permeability in children with autism. Acta Paediatrica, 85(9), 1076–1079.PubMedCrossRefGoogle Scholar
  7. Drucker, D. J. (2005). Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nature Clinical Practice Endocrinology & Metabolism, 1(1), 22–31.CrossRefGoogle Scholar
  8. Erickson, C. A., Stigler, K. A., Corkins, M. R., Posey, D. J., Fitzgrald, J. F., & McDougle, C. J. (2005). Gastrointestinal factors in autistic disorder: A critical review. Journal of Autism and Developmental Disorders, 35(6), 713–727.PubMedCrossRefGoogle Scholar
  9. Estall, J. L., & Drucker, D. J. (2006). Glucagon-like Peptide-2. Annual Review of Nutrition, 26, 391–411.PubMedCrossRefGoogle Scholar
  10. Field, D., Garland, M., & Williams, K. (2003). Correlates of specific childhood feeding problems. Journal of Paediatrics and Child Health, 39(4), 299–304.PubMedCrossRefGoogle Scholar
  11. Furlano, R. I., Anthony, A., Day, R., Brown, A., & McGarvey, L. et al. (2001). Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. The Journal of Pediatrics, 138(3), 366–372.PubMedCrossRefGoogle Scholar
  12. Horvath, K., Papadimitriou, J. C., Rabsztyn, A., Drachenberg, C., & Tildon, J. T. (1999). Gastrointestinal abnormalities in children with autistic disorder. The Journal of Pediatrics 135(5), 559–563.PubMedCrossRefGoogle Scholar
  13. Horvath, K., Zielke, R. H., Collins, R. M., Rabsztyn, A., Medeiros, L. A., & Perman, J. (2000). Secretin improves intestinal permeability in autistic children. Journal of Pediatric Gastroenterology Nutrition, 31, S31.Google Scholar
  14. James, M. W., & Scott, B. B. (2000). Endomysial antibody in the diagnosis and management of coeliac disease. Postgraduate Medical Journal, 76(898), 466–468.PubMedCrossRefGoogle Scholar
  15. Kuddo, T., & Nelson, K. B. (2003). How common are gastrointestinal disorders in children. Current Opinion in Pediatrics, 15, 339–343.PubMedCrossRefGoogle Scholar
  16. Liu, Z., & Neu, J. (2005). Tight junctions, leaky intestines, and pediatric diseases. Acta Pediatrica., 94(4), 386–393.CrossRefGoogle Scholar
  17. Marsilio, R., D’Antiga, L., Zancan, L., Dussini, N., & Zacchello, F. (1998) Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clinical Chemistry, 44, 1685–1691.PubMedGoogle Scholar
  18. Martin, G. R., Wallace, L. E., & Sigalet, D. L. (2004). Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. American Journal of Physiology. Gastrointestinal and Liver Physiology, 286(6), G964–G972.PubMedCrossRefGoogle Scholar
  19. Martin, G. R., Beck, P. L., & Sigalet, D. L. (2006). Gut hormones, and short bowel syndrome: The enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World Journal of Gastroenterology, 12(26), 4117–4129.PubMedGoogle Scholar
  20. May, G. R., Sutherland, L. R., & Meddings, J. B. (1993). Is small intestinal permeability really increased in relatives of patients with Crohn’s disease? Gastroenterology, 104(6), 1627–1632.PubMedGoogle Scholar
  21. Meddings, J. B., Sutherland, L. R., & May, G. R. (1994). Intestinal permeability in patients with Crohn’s disease. Gut, 35(11), 1675–1676.PubMedCrossRefGoogle Scholar
  22. Meddings, J. B. (1997). Review article: Intestinal permeability in Crohn’s disease. Alimentary Pharmacology & Therapeutics, 11(Suppl 3), 47–53 (discussion 53–56).Google Scholar
  23. Molloy, C. A., & Manning-Courtney, P (2003). Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders. Autism, 7(2), 165–171.PubMedCrossRefGoogle Scholar
  24. Murphy, M. S., Eastham, E. J., Nelson, R., Pearson, A. D. J., & Laker, M. F. (1989) Intestinal permeability in Crohn’s Disease. Archives of Disease in Childhood, 64, 321–325.PubMedCrossRefGoogle Scholar
  25. Raiten, D. J., & Massaro, T. (1986). Perspectives on the nutritional ecology of autistic children. Journal of Autism and Developmental Disorders, 16(2), 133–143.PubMedCrossRefGoogle Scholar
  26. Rice, C., (2007) Prevalence of autism spectrum disorders–Autism and developmental disabilities monitoring network, 14 Sites, United States, 2002. MMWR Surveillance Summaries, 56 (SS01); 12–28.Google Scholar
  27. Shattock, P., & Whiteley, P. (2002). Biochemical aspects in autism spectrum disorders: Updating the opioid-excess theory and presenting new opportunities for biomedical intervention. Expert Opinion on Therapeutic Targets, 6(2), 175–183.PubMedCrossRefGoogle Scholar
  28. Sigalet, D. L., Martin, G., Meddings, J., Hartman, B., & Holst, J. J. (2004). GLP-2 levels in infants with intestinal dysfunction. Pediatric Research, 56(3), 371–376.PubMedCrossRefGoogle Scholar
  29. Sigalet, D. L., Bawazir, O., Martin, G. R., Wallace, L. E., Zaharko, G., Miller, A., & Zubaidi, A. (2006). Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Digestive Diseases and Sciences, 51(9), 1557–1566.PubMedCrossRefGoogle Scholar
  30. Topstad, D., Martin, G., & Sigalet, D. (2001). Systemic GLP-2 levels do not limit adaptation after distal intestinal resection. Journal of Pediatric Surgery, 36(5), 750–754.PubMedCrossRefGoogle Scholar
  31. Torrente, F., Ashwood, P., Day, R., Machado, N., & Furlano, R. I. et al. (2002). Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Molecular Psychiatry, 7(4), 375–382.PubMedCrossRefGoogle Scholar
  32. Valicenti-McDermott, M., McVicar, A., Rapin, I., Wershil, B. K., Cohen, H., & Shinnar, S., (2006). Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease. Journal of Developmental and Behavioral Pediatrics, 27, S128–S136.PubMedCrossRefGoogle Scholar
  33. Van Elburg, R. M., Uil, J. J., Mulder, C. J., & Heymans, H. S. (1993). Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut, 34, 354–357.PubMedCrossRefGoogle Scholar
  34. Van Elburg, R. M., Uil, J. J., Kokke, F. T., Mulder, A. M., van der Broek, W. G., Mulder, C. J., & Heymans, H. S. (1995). Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars. Journal of Pediatric Gastroenterology Nutrition, 20, 184–188.CrossRefGoogle Scholar
  35. Wakefield, A. J., Murch, S. H., Anthony, A., Linnell, J., & Casson, D. M., et al. (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet, 351(9103), 637–641.PubMedCrossRefGoogle Scholar
  36. Wakefield, A. J., Anthony, A., Murch, S. H., Thomson, M., & Montgomery, S. M. et al. (2000). Enterocolitis in children with developmental disorders. The American Journal of Gastroenterology, 95(9), 2285–2295.PubMedCrossRefGoogle Scholar
  37. Wakefield, A. J., Puleston, J. M., Montgomery, S. M., Anthony, A., & O’Leary, J. J. et al. (2002). Review article: The concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacology & Therapeutics, 16(4), 663–674.CrossRefGoogle Scholar
  38. Wakefield A. J., Ashwood P., Limb K., & Anthony, A. (2005). The significance of ileo-colonic lymphoid nodular hyperplasia in children with autistic spectrum disorder. European Journal of Gastroenterology & Hepatology, 17(8), 827–836.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Marli A. Robertson
    • 1
    • 2
  • David L. Sigalet
    • 3
    • 4
  • Jens J.  Holst
    • 5
  • Jon B. Meddings
    • 6
  • Julie Wood
    • 7
  • Keith A. Sharkey
    • 3
    • 8
  1. 1.Department of PediatricsUniversity of CalgaryCalgaryCanada
  2. 2.Alberta Children’s HospitalCalgaryCanada
  3. 3.Institute of Infection, Immunity and InflammationUniversity of CalgaryCalgaryCanada
  4. 4.Department of SurgeryUniversity of CalgaryCalgaryCanada
  5. 5.Department of Medical PhysiologyUniversity of CopenhagenCopenhagenDenmark
  6. 6.Department of MedicineUniversity of AlbertaEdmontonCanada
  7. 7.Gastroenterology and NutritionAlberta Children’s HospitalCalgaryCanada
  8. 8.Department of Physiology and BiophysicsUniversity of CalgaryCalgaryCanada

Personalised recommendations